| Symbol |
Name |
|
ACVRL1
|
activin A receptor type II-like 1
|
|
AGGF1
|
angiogenic factor with G patch and FHA domains 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCBE1
|
collagen and calcium binding EGF domains 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
ENG
|
endoglin
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCE
|
Fanconi anemia, complementation group E
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FANCG
|
Fanconi anemia, complementation group G
|
|
FANCI
|
Fanconi anemia, complementation group I
|
|
FANCL
|
Fanconi anemia, complementation group L
|
|
FANCM
|
Fanconi anemia, complementation group M
|
|
FAT4
|
FAT atypical cadherin 4
|
|
GDF2
|
growth differentiation factor 2
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GUSB
|
glucuronidase, beta
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
NSDHL
|
NAD(P) dependent steroid dehydrogenase-like
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PTEN
|
phosphatase and tensin homolog
|
|
RAD51C
|
RAD51 paralog C
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RBM10
|
RNA binding motif protein 10
|
|
RBM8A
|
RNA binding motif protein 8A
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMAD4
|
SMAD family member 4
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
